Bristol-Myers Squibb Announces Dividend Increase

Bristol-Myers Squibb Announces Dividend Increase

NEW YORK--(BUSINESS WIRE)--The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared a 3.2 percent increase in the company's quarterly dividend, beginning in the first quarter of 2010.

"This dividend increase reflects our ongoing commitment to deliver shareholder value," said James M. Cornelius, chairman and chief executive officer of Bristol-Myers Squibb. "We have made excellent progress in executing our strategy and we are confident in the strength of our BioPharma business. Our performance has helped put us in a strong cash position today and we expect solid cash flows to continue in the years ahead."

The dividend increase will result in a quarterly dividend of thirty-two cents ($0.32) per share on the $.10 par value Common Stock of the corporation for an indicative 2010 full-year dividend of $1.28 per share, subject to the normal quarterly review by the Board. The next quarterly dividend will be payable on February 1, 2010 to stockholders of record at the close of business on January 4, 2010.

The Directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable March 3, 2010 to stockholders of record at the close of business on February 8, 2010.

Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. For more information, visit:

Suggested Articles

Genor Biopharma banked $160 million from the likes of Hillhouse and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs.

Going from being the CSO of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major career shift.

Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development.